Annual report pursuant to Section 13 and 15(d)

Schedule I - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details)

v3.22.4
Schedule I - Condensed Financial Information of Registrant - Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 1,353 [1] $ 1,404
Other current assets 97 207
Total current assets 5,608 5,056
Capitalized interest associated to investment in subsidiaries, net of amortization 31,528 30,288
Operating lease assets 2,625 2,102
Deferred tax assets 864 1,204
Total assets 41,266 [1] 39,258
Current liabilities    
Current operating lease liabilities 616 535
Other current liabilities 28 94
Total current liabilities 6,795 4,693
Long-term debt, net of debt issuance costs 24,055 29,449
Operating lease liabilities 1,971 1,541
Other non-current liabilities 175 50
Stockholders' deficit (2,969) (2,571)
Total liabilities and stockholders’ deficit 41,266 [1] 39,258
Cheniere [Member]    
Current assets    
Cash and cash equivalents 0 17
Other current assets 6 1
Total current assets 6 18
Capitalized interest associated to investment in subsidiaries, net of amortization 38 35
Operating lease assets 64 19
Debt issuance and deferred financing costs, net of accumulated amortization 12 16
Deferred tax assets 92 797
Total assets 212 885
Current liabilities    
Current operating lease liabilities 7 6
Other current liabilities 18 30
Total current liabilities 25 36
Long-term debt, net of debt issuance costs 1,477 2,285
Investments in subsidiaries 1,552 1,110
Operating lease liabilities 69 24
Other non-current liabilities 58 1
Stockholders' deficit (2,969) (2,571)
Total liabilities and stockholders’ deficit $ 212 $ 885
[1] Amounts presented include balances held by our consolidated variable interest entity (“VIE”), CQP, as further discussed in Note 9—Non-controlling Interest and Variable Interest Entity. As of December 31, 2022, total assets and liabilities of CQP were $18.9 billion and $21.7 billion, respectively, including $0.9 billion of cash and cash equivalents and $0.1 billion of restricted cash and cash equivalents.